Body size and prostate cancer risk

July 14, 2017, University of Oxford
Body size and prostate cancer risk. Credit: Shutterstock

Prostate cancer is the most common cancer in men in Europe and the second most frequently diagnosed cancer in men worldwide.

A new study led by researchers in the Nuffield Department of Population Health Cancer Epidemiology Unit (CEU) investigated the associations of height and obesity with by different characteristics and death from prostate cancer and found that taller men and men with more fat are at greater risk of high grade prostate cancer and death from prostate cancer. The research was based on data from 141,896 men in eight countries from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort and included a total of 7,024 prostate cancer cases.

The study results showed an 18% greater risk of death from prostate cancer and a 13% greater risk of high grade cancer with every 10 cm increase in waist circumference. The research also found that while height was not associated with overall , the risk of high grade disease increased by 21% and the risk of death from prostate cancer increased by 17% with every additional 10 cm in height.

The innovative aspect of this study was its focus on different tumour sub-types. The researchers distinguished between the stage (or spread) and the histological grade of the cancer. A tumour that has spread outside the prostate is described as advanced stage, whereas one contained within the prostate is defined as localized stage. The histological grade of the cancer (high, intermediate or low) refers to how abnormal tumour cells look compared to normal cells. Most previous research in this area has grouped the stage and grade of tumour together in combined categories of aggressive or non-aggressive cancer.

Credit: University of Oxford

Lead author, Dr Aurora Perez-Cornago, said: "The results emphasise the importance of studying risk factors for prostate cancer separately for advanced stage and high grade tumours. There is nothing men can do about their height but at least it is now more evident that they may reduce their risk of aggressive by having a healthy weight. However, further research is still needed to understand possible mechanisms, such as hormonal alterations, and to establish whether the associations we have seen are causal."

Explore further: Study finds that higher BMI and waist circumference are associated with increased risk of aggressive prostate cancer

More information: Aurora Perez-Cornago et al. Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study, BMC Medicine (2017). DOI: 10.1186/s12916-017-0876-7

Related Stories

Study finds that higher BMI and waist circumference are associated with increased risk of aggressive prostate cancer

June 2, 2016
A study of almost 150,000 men from 8 European countries, presented at this year's European Obesity Summit (Gothenburg, 1-4 June) shows that higher body mass index (BMI) and waist circumference are associated with an increased ...

Are men with a family history of prostate cancer eligible for active surveillance?

April 6, 2017
Active surveillance—careful monitoring to determine if or when a cancer warrants treatment—is an increasingly prevalent choice for prostate cancer, but it's unclear if the strategy is appropriate for men with a family ...

New findings concerning hereditary prostate cancer

July 11, 2016
It is a well-known fact that men with a family history of prostate cancer run an increased risk of developing the disease. The risk for brothers of men with prostate cancer is doubled. But a doubled risk of what, exactly? ...

Prostate cancer tied to higher colorectal cancer risk

March 1, 2016
(HealthDay)—The risk of colorectal cancer is increased after a diagnosis of prostate cancer, according to a study published online Feb. 25 in Cancer.

More accurate prostate cancer prognosis

August 2, 2016
Men diagnosed with prostate cancer can be provided with a more accurate estimate of their risk of death from the disease, and treatment planned accordingly, according to a Research Article published by Vincent J. Gnanapragasam, ...

Marker for aggressive prostate cancer doubles up as a drug target

November 8, 2016
Researchers have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to guide treatments to the cancer, according to new research presented at the National Cancer Research Institute ...

Recommended for you

Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

February 23, 2018
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

An under-the-radar immune cell shows potential in fight against cancer

February 23, 2018
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.